Norbert Gattermann

8.4k citations

55 papers · 4.5k indexed · 2 hit papers · h-index 26

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders

Papers in

Hematology 48
- Acute Myeloid Leukemia Research 45
- Iron Metabolism and Disorders 4
Genetics 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
- Hemoglobinopathies and Related Disorders 9
- Blood disorders and treatments 4

Co-authors: Aristoteles Giagounidis Pierre Fenaux Ghulam J. Mufti Alan F. List Valeria Santini Steven D. Gore John F. Seymour Guillermo Sanz
Journals: Leukemia Research (21 papers)British Journal of Haematology (4 papers)Annals of Hematology (3 papers)Blood (3 papers)Cancer (2 papers)
Partner nations: Germany United States Italy

In The Last Decade

Norbert Gattermann

50 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study 2009 · 1.8k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 The Lancet Oncology
2009 Journal of Clinical Oncology

Peers

Countries citing papers authored by Norbert Gattermann

Since Specialization

Citations

This map shows the geographic impact of Norbert Gattermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Gattermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Gattermann more than expected).

Fields of papers citing papers by Norbert Gattermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Gattermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Gattermann. The network helps show where Norbert Gattermann may publish in the future.

Co-authors

The 25 scholars most cited alongside Norbert Gattermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norbert Gattermann Line = papers co-authored together Norbert Gattermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Iron overload in acquired sideroblastic anemias and MDS: pathophysiology and role of chelation and luspatercept Hematology ·Norbert Gattermann	2024	3
2	DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study British Journal of Haematology ·Ludovico Scriva, Ignacio Campillo‐Marcos, Verónica Dávalos, Carlos A. García‐Prieto, David Valcárcel, 英里香菊地, Laura Palomo, Norbert Gattermann, Michael Wulfert, Wang Guo-fang, Françesc Solé, Susan Duan, Zhaohuan Li, Blanca Xicoy, Lurdes Zamora, 剛志斉藤, 黃文志, Carlo Finelli, Matilde Y. Follo, Manel Esteller	2024	1
3	Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial Clinical Lymphoma Myeloma & Leukemia ·Guillermo Garcia‐Manero, António Almeida, Pierre Fenaux, Norbert Gattermann, Aristoteles Giagounidis, Stuart L. Goldberg, Keiya Ozawa, Jerry Weaver, Valeria Santini	2018	3
4	New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types Leukemia Research ·Corinna Strupp, Kathrin Nachtkamp, Barbara Hildebrandt, Aristoteles Giagounidis, Rainer Haas, Norbert Gattermann, John M. Bennett, Carlo Aul, Ulrich Germing	2017	19
5	Causes of death in 2877 patients with myelodysplastic syndromes Annals of Hematology ·Kathrin Nachtkamp, Sp., Corinna Strupp, Andrea Kündgen, Aristoteles Giagounidis, Carlo Aul, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing	2016	63
6	Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome – Emphasis on optimized dosing schedules and new formulations Leukemia Research ·Florian Nolte, Emanuele Angelucci, Massimo Breccia, Norbert Gattermann, Valeria Santini, Norbert Vey, Wolf-Karsten Hofmann	2015	13
7	Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload Annals of Hematology ·Florian Nolte, Britta Höchsmann, Aristoteles Giagounidis, Michael Lübbert, Uwe Platzbecker, Dagmar Haase, Maximilian Kohlhof, Norbert Gattermann, Matthias Taupitz, Monika Baier, Zhenghua Peng, Reema Syed, Christiane Schumann, W.‐K. Hofmann, Hubert Schrezenmeier	2012	64
8	Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts Leukemia Research ·Kozma János, Corinna Strupp, Aristoteles Giagounidis, Andrea Kuendgen, Kathrin Nachtkamp, Barbara Hildebrandt, Norbert Gattermann, Carlo Aul, Rainer Haas, Ulrich Germing	2012	28
9	Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes Leukemia Research ·Ulrich Germing, Corinna Strupp, Aristoteles Giagounidis, Rainer Haas, Norbert Gattermann, C. Starke, Carlo Aul	2012	54
10	Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study Leukemia Research ·Norbert Gattermann, Carlo Finelli, Matteo Giovanni Della Porta, Pierre Fenaux, Arnold Ganser, Agnès Guerci‐Bresler, Mathias Schmid, Kerry Taylor, (unknown), Sy Ha, Gabor Domokos, Bernard Roubert, Christian Rosé	2010	138
11	Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia Journal of Clinical Oncology ·Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg, Valeria Santini, Norbert Gattermann, Ulrich Germing, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour, Hervé Dombret, Jay T. Backstrom, A. Mazen, David R. McKenzie, C.L. Beach, Lewis R. Silverman Hit paper breakdown →	2009	698
12	Impact on survival of different treatments for myelodysplastic syndromes (MDS) Leukemia Research ·Kathrin Nachtkamp, Andrea Kündgen, Corinna Strupp, Aristoteles Giagounidis, Guido Kobbe, Norbert Gattermann, Rainer Haas, Ulrich Germing	2009	34
13	Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome International Journal of Hematology ·Wolf Christian Prall, Akos Czibere, Franck Grall, Dimitrios Spentzos, Ulrich Steidl, Aristoteles Giagounidis, Andrea Kuendgen, Hasan H. Otu, Surat Sriworawit, Towia A. Libermann, Ulrich Germing, Norbert Gattermann, Rainer Haas, Manuel Aivado	2009	22
14	Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study The Lancet Oncology ·Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour, John M. Bennett, John C. Byrd, Jay T. Backstrom, A. Mazen, David R. McKenzie, C.L. Beach, Lewis R. Silverman Hit paper breakdown →	2009	1756
15	Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome Leukemia Research ·Sabine Knipp, Corinna Strupp, Norbert Gattermann, Barbara Hildebrandt, M Schapira, Aristoteles Giagounidis, Carlo Aul, Rainer Haas, Ulrich Germing	2007	17
16	Iron overload in MDS: clinical consequences and management strategies Leukemia Research ·Norbert Gattermann	2007	0
17	Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals British Journal of Haematology ·Ulrich Germing, Corinna Strupp, Andrea Kuendgen, Manuel Aivado, Aristoteles Giagounidis, Barbara Hildebrandt, Carlo Aul, Rainer Haas, Norbert Gattermann	2005	15
18	Myocardial regeneration after intracoronary transplantation of human autologous stem cells following acute myocardial infarction DMW - Deutsche Medizinische Wochenschrift ·Bodo E. Strauer, Merel‐Anne Brehm, Tobias Zeus, Norbert Gattermann, Xu-Lin He, Rüdiger V. Sorg, Gesine Kögler, Peter Wernet	2004	159
19	Hemoglobinopathy York [β146 (HC3) His⇒Pro]: first report of a family history Annals of Hematology ·G. Rosso, Norbert Gattermann, LeeJin Park, Mayán José Manuel, Ulrike Peters, E. Kohne	2001	6
20	Long‐term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis British Journal of Haematology ·Manuel Aivado, Surat Sriworawit, Ulrich Germing, Norbert Gattermann, Guido Kobbe, Antonio Orozco Villar, 正裕立野, Hongyi Lin	2000	19

About Norbert Gattermann

Norbert Gattermann is a scholar working on Hematology, Genetics, Emergency Medicine, Orthopedics and Sports Medicine and Rheumatology, having authored 55 papers that have together received 4.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (45 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Hematological disorders and diagnostics (10 papers), Hemoglobinopathies and Related Disorders (9 papers), Acute Lymphoblastic Leukemia research (6 papers), Blood disorders and treatments (4 papers), Iron Metabolism and Disorders (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (3.6k citations), Genetics (1.6k citations), Emergency Medicine (309 citations), Molecular Biology (1.7k citations) and Public Health, Environmental and Occupational Health (672 citations). Norbert Gattermann has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Aristoteles Giagounidis, Pierre Fenaux, Ghulam J. Mufti, Alan F. List, Valeria Santini, Steven D. Gore, John F. Seymour, Guillermo Sanz, Lewis R. Silverman and Eva Hellström‐Lindberg. Their work appears in journals such as Leukemia Research, British Journal of Haematology, Annals of Hematology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact